Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib

作者:Breccia Massimo*; Salaroli Adriano; Serrao Alessandra; Zacheo Irene; Saracino Roberta; Alimena Giuliana
来源:Leukemia and Lymphoma, 2014, 55(1): 204-206.
DOI:10.3109/10428194.2013.795650